Indeed, knockout or blockade of IFNAR1 was sufficient to block the enhancement of antigen presentation by BCL2 inhibition in de-iniDCs in vitro, as well as their tumor growth controlling activity in vivo. Here, BCL2 is linked to neoplasm.